Sara Mastaglio

Also affiliated with San Raffaele University of Rome, IRCCS Ospedale San Raffaele, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The first case of COVID-19 treated with the complement C3 inhibitor AMY-101”.

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Clinical Immunology(2020)10.1016/j.clim.2020.108450

N/A

0DataRank · unranked

297 citations

Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos +7 more

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Clinical Immunology(2020)10.1016/j.clim.2020.108598

N/A

0DataRank · unranked

265 citations

Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, Natasha Peixoto Fonseca, Maria Auxiliadora‐Martins, Sara Mastaglio +18 more